Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579299 · ClinicalTrials.gov registry record · NA
Engaging Family Members During Early SUD Treatment: A Hybrid Trial
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07579299: Clinical Trial NA study, sponsored by Stanford University.
NCT07579299 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07579299, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this study is a fractional factorial optimization trial to optimize engagement in a CRAFT program for family members with loved ones in outpatient treatment for a substance use disorder. This study aims to identify family engagement strategies that are feasible, acceptable, and appropriate and effective in increasing family member initiation with CRAFT. Participants will complete an iterative, online process where they will evaluate and rank different engagement strategies to identify the most optimal in increasing engagement and then participate in an optimization trial to identify which strategies were most effective in increasing family member engagement.
Primary Outcome
Attend at least 1 eINSPIRE session
Interventions
- BEHAVIORAL Placebo
- BEHAVIORAL Engagement Strategy 1
- BEHAVIORAL Engagement Strategy 2
- BEHAVIORAL Engagement Strategy 3
- BEHAVIORAL Engagement Strategy 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What is known before NCT07579299 opens enrollment
NCT07579299 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT07579299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07579299 about?
NCT07579299 is a clinical study titled "Engaging Family Members During Early SUD Treatment: A Hybrid Trial". The goal of this study is a fractional factorial optimization trial to optimize engagement in a CRAFT program for family members with loved ones in outpatient treatment for a substance use disorder. This study aims to identify family engagement strategies that are feasible, acceptable, and appropri...
What is the current status of trial NCT07579299?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07-15. Estimated completion is 2027-03-31.
What interventions are being tested in trial NCT07579299?
The interventions under investigation include: Placebo (BEHAVIORAL), Engagement Strategy 1 (BEHAVIORAL), Engagement Strategy 2 (BEHAVIORAL), Engagement Strategy 3 (BEHAVIORAL), Engagement Strategy 4 (BEHAVIORAL).
Who is sponsoring clinical trial NCT07579299?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07579299's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI